The yellow fever mosquito, *Aedes aegypti*, is the primary vector of arthropod-borne viruses that include dengue, yellow fever, chikungunya, and Zika ([@CIT0015], [@CIT0002], [@CIT0014]). These pathogens are a persistent threat to people in regions where *Ae. aegypti* is established, and with the recent and projected range expansion of *Ae. aegypti* ([@CIT0003]), risk of transmission of these viruses is also spreading. During the 2015--2016 Zika virus outbreak in the Americas, many urban areas in the southern and southeastern United States became acutely aware of this new threat ([@CIT0006]). Due to the lack of vaccine for Zika, chikungunya, and dengue viruses, mosquito control is the primary method utilized to minimize mosquito bite encounters, thereby decreasing the risk of infection ([@CIT0013], [@CIT0026]).

In California, *Ae. aegypti* were first detected in 2013, and enhanced surveillance revealed populations were well established in the surrounding urban area ([@CIT0030], [@CIT0011]). By the end of 2018, detections had been made in 222 cities and census designated areas in 13 counties, spanning a large portion of the urbanized central and southern regions of the state ([@CIT0004]). Studies on the population genetics of *Ae. aegypti* in California have identified two genetically distinct populations: the 'central' population (San Mateo, Fresno, Madera, and Tulare counties) and the 'southern' population (Orange, San Diego, and Los Angeles counties), having likely originated in the South Central United States and Southwest United States/northern Mexico regions, respectively ([@CIT0005], [@CIT0016]). Though introduction and establishment of this invasive species was cause for concern given the number of travel-related cases of dengue and chikungunya in California each year ([@CIT0017]), the outbreak of Zika virus beginning in 2015 brought the issue to the forefront.

In November 2015, the first cases of Zika virus were reported in California ([@CIT0018]). The California Department of Public Health (CDPH) and local health departments investigated each case and determined that all cases were travel-associated. While no local *Aedes* mosquito-borne disease transmission has occurred in California to date, the possibility does exist. Small Zika virus outbreaks occurred in two other states in the continental United States with established *Ae. aegypti* populations: Florida and Texas ([@CIT0006]). Given the significant outcomes of Zika virus infection on pregnant women and their fetuses ([@CIT0028]), it is imperative to develop preparedness plans in which adult mosquito control plays a primary role to halt local transmission.

Insecticide resistance in *Ae. aegypti* has been well documented in many parts of the world ([@CIT0012], [@CIT0009], [@CIT0010], [@CIT0025], [@CIT0022]). One of the most common chemical classes of pesticides used to control adult *Ae. aeygpti* are pyrethrin-based (e.g., pyrethroids) because they are relatively low in cost and toxicity to mammals ([@CIT0027]). Knockdown resistance (*kdr*) results from a nonsynonymous mutation occurring on the voltage-sensitive sodium channel (*Vssc*) transmembrane protein that prevents pyrethroid insecticides from attaching properly and causing mortality ([@CIT0023]). There are several single nucleotide polymorphism mutations along the *Vssc* known to confer *kdr*-type resistance in *Ae. aegypti*. In the Americas, two of the most common mutations are substitutions occurring at codon 1016, resulting in an amino acid change of valine (V) to isoleucine (I) (V1016I), and at codon 1534, resulting in an amino acid change of phenylalanine (F) to cysteine (C) (F1534C) ([@CIT0021]). Analyses of adult *Ae. aegypti* from Fresno County, California, collected in 2013 indicated high levels of resistance to certain pyrethroid adulticides, as well as fixed resistant mutations at the 1016 locus ([@CIT0004a]). Biological assays of the CLOVIS strain also indicated decreased susceptibility to sumithrin, pyrethrum, and permethrin ([@CIT0004a]).

In 2017, CDPH initiated an *Ae. aegypti* pesticide resistance testing program designed to screen for the V1016I and F1534C mutations. Herein, we describe the *kdr*-type genetic profiles of *Ae. aegypti* collected from the central and southern infestation zones in California from 2015 through 2017. Using samples collected by multiple local vector control agencies, we determined the proportion of resistant alleles at the 1016 and 1534 loci. Due to the focal nature of *Ae. aegypti* ([@CIT0007]), the resistance frequencies were analyzed at both county and regional levels, and where possible, temporally. These results will help vector control agencies develop a plan to combat the spread of *Ae. aegypti* and effectively reduce the risk of local disease transmission.

Materials and Methods {#s1}
=====================

Mosquito Samples 2015 {#s2}
---------------------

Adult *Ae. aegypti* mosquitoes collected by local California vector control agencies were submitted to Yale University for genetic analysis and DNA was extracted as described in [@CIT0016]. Aliquots of 80 µl of extracted DNA maintained in a cold chain to prevent degradation were provided to CDPH for pesticide resistance analysis.

Mosquito Samples 2016--2017 {#s3}
---------------------------

Adult *Ae. aegypti* mosquitoes were collected by local California vector control agencies from October 2016 through December 2017 using multiple sampling schemes, including CDC Autocidal Gravid Ovitraps (CDC-AGOs), BioGents Sentinel (BGS) traps, Encephalitis Vector Survey (EVS) traps, and backpack aspirators. Larval and pupal samples were also collected through source surveys, and raised to adults in the laboratory. Agencies stored adult mosquitoes individually in empty and dry 1.5 ml Eppendorf tubes at −80°C or in a dry ice chest. Where cold storage access was limited, mosquitoes were preserved in 70% ethanol. Mosquitoes were shipped to CDPH, maintaining the cold chain for all dry specimens.

Upon receipt, all adult mosquito samples were stored at −80°C prior to processing. Abdomens were removed from all dry, female samples that were collected in a live-trap or reared in a laboratory. These abdomens and all remaining mosquitoes were then stored in 70% ethanol at −20°C in preparation for extraction. The head and thoraces of viable mosquitoes were stored at −80°C for future analyses.

Genotyping Assays {#s4}
-----------------

DNA extractions of abdomens or whole mosquitoes were conducted using Qiagen DNeasy Blood and Tissue Kit per the manufacturer's protocol (Qiagen, Hercules, CA). DNA samples were eluted to a final volume of 200 µl.

Identification of *kdr*-type *Vssc* mutations was conducted using melt-curve assays. For the V1016I mutation, the protocol described by [@CIT0021] was slightly modified. The 21 µl reaction mixture contained 10 µl of iQ Syber Green Supermix (Bio-Rad, Hercules, CA), 2.5 µl of the valine forward primer (5′-GCGGGCAGGGCGGCGGGGGCGGGGCCACAAATTGTTTCCCACCCGCACCGG-3′), 2 µl of the isoleucine forward primer (5′-GCGGGCACAAATTGTTTCCCACCCGCACTGA-3′), 2 µl of the reverse primer (5′-TGATGAACCSGAATTGGACAAAAGC-3′), 3.5 µl PCR-grade water, and 1 µl of DNA template. All primer concentrations were 10 µM. Amplification consisted of 95°C for 3 min, followed by 35 cycles of 95°C for 10 s, 60°C for 10 s, and 72°C for 30 s. The melt-curve protocol followed with 10 s each at 0.2°C increments between 65 and 95°C. Melt curves were generated by the CFX Manager Software Version 3.1 (Bio-Rad) in which homozygous susceptible individuals had a single peak at 86°C (V/V), heterozygous individuals had two peaks at 79°C and 86°C (V/I), and homozygous resistant individuals had a single peak at 79°C (I/I).

The F1534C mutation was identified using a slightly modified protocol described by [@CIT0029]. The 20 µl reaction mixture contained 10 µl of iQ Syber Green Supermix (Bio-Rad), 0.33 µl of the phenylalanine forward primer (5′-GCGGGCTCTACTTTGTGTTCTTCATCATATT-3′), 1 µl of the forward cysteine primer (5′-GCGGGCAGGGCGGCGGGGGCGGGGCCTCTACTTTGTGTTCTTCATCATGTG-3′), 1 µl of the reverse primer (5′-TCTGCTCGTTGAAGTTGTCGAT-3′), 5.67 µl PCR-grade water, and 2 µl of DNA template. All primer concentrations were 10 µM. Amplification consisted of 95°C for 3 min, followed by 35--40 cycles of 95°C for 10 s, 57°C for 10 s, and 72°C for 30 s. The melt-curve protocol followed with 5 s each at 0.5°C increments between 65 and 95°C. Melt curves were generated by the CFX Manager Software Version 3.1 (Bio-Rad) in which homozygous susceptible individuals had a single peak at 80°C (F/F), heterozygous individuals had two peaks at 80°C and 85°C (F/C), and homozygous resistant individuals had a single peak at 85°C (C/C).

Analysis {#s5}
--------

Analyses of the resistant and susceptible alleles for each mutation locus were conducted at two geographic levels: by region (central and southern) and by county. The frequency of each mutation in a given population was calculated using the following allelic frequency formula:
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where F~p~= the frequency of the resistant allele, p = resistant allele, q = susceptible allele, and n = total number of samples.

Geographic maps of allelic frequencies were created using the ggplot2, ggmap, maps, and mapdata libraries for the R statistical software package ([@CIT0024]).

Results {#s6}
=======

Mosquito Samples {#s7}
----------------

From 2015 through 2017, a total of 4,968 mosquitoes were submitted for testing from 11 California counties. Of these, 4,076 whole mosquitoes and 892 mosquito abdomens were tested. Conclusive results for the V1016I and F1534C assays were obtained from 4,852 and 4,870 samples, respectively ([Table 1](#T1){ref-type="table"}).

###### 

Allelic frequencies of the V1016I and F1534C mutations by region of the state and year (central---Fresno, Kern, Madera, Merced, and Tulare counties; southern---Imperial, Los Angeles, Orange, Riverside, San Bernardino, and San Diego counties), California, 2015 through 2017

  Region     Year             V1016I                                                    F1534C                                      
  ---------- ---------------- ----------- --------- ----------- ----------- ----------- ----------- --------- --------- ----------- ------------
  Central    2015             42          0         0           42          100.0%      44          0         0         44          100.0%
             2016             160         0         0           160         100.0%      161         0         0         161         100.0%
             2017             1,047       0         14          1,027       98.8%       1,047       0         0         1,047       100.0%
             **2015--2017**   **1,249**   **0**     **14**      **1,229**   **99.0%**   **1,252**   **0**     **0**     **1,252**   **100.0%**
  Southern   2015             143         58        65          20          36.7%       145         56        53        36          43.1%
             2016             212         43        97          72          56.8%       214         27        66        121         72.0%
             2017             3,248       538       1,370       1,339       62.3%       3,259       197       477       2,585       86.6%
             **2015--2017**   **3,603**   **639**   **1,532**   **1,431**   **61.0%**   **3,618**   **280**   **596**   **2,742**   **84.0%**

SS, indicates homozygous susceptible; SR, heterozygous; RR, homozygous resistant individuals

Analysis {#s8}
--------

California counties were divided into two populations: central (Fresno, Kern, Madera, Merced, and Tulare counties) and southern (Imperial, Los Angeles, Orange, Riverside, San Bernardino, and San Diego counties) based on the analysis by [@CIT0016]. The frequency of the resistant genotypes for the V1016I and F1534C mutations in the central population is nearly fixed at 100% ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Of the 1,249 mosquitoes tested from 2015 through 2017, only 14 contained a susceptible allele for the 1016, and no samples were homozygous susceptible. For the 1534 mutation, no susceptible alleles were identified in the 1,252 samples tested ([Table 1](#T1){ref-type="table"}).

![Proportions of the susceptible and resistant alleles of the 1016 locus mutation at a regional-level by year.](tjz076f0001){#F1}

![Proportions of the susceptible and resistant alleles of the 1534 locus mutation at a regional-level by year.](tjz076f0002){#F2}

The resistance allele profile in the southern population of the state differed from the central population. In 2015, the frequency of the resistant allele was less than 50% in the southern population for both V1016I and F1534C (36.71 and 43.10%, respectively; [Table 1](#T1){ref-type="table"}, [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The regional resistant allele percentages increased each year, reaching as high as 62.32 and 86.64%, respectively, in 2017 ([Table 1](#T1){ref-type="table"}, [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Of the counties included in the southern region population, Orange County was the only one with three consecutive years of data, showing that even on a smaller county level, the frequency of the resistant alleles increased over time. From 2015 through 2017, the percentage of resistant alleles increased by nearly 2-fold for the 1016 mutation locus, and 2.5-fold for the 1534 mutation locus ([Table 2](#T2){ref-type="table"}, [Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

###### 

Allelic frequencies of the V1016I and F1534C mutations by region (central and southern), year, and county, California, 2015 through 2017

         Region     County           V1016I                              F1534C                     
  ------ ---------- ---------------- -------- ----- ----- ----- -------- -------- ----- ----- ----- --------
  2015   Central    Fresno           20       0     0     20    100.0%   20       0     0     20    100.0%
         Central    Madera           22       0     0     22    100.0%   24       0     0     24    100.0%
         Southern   Orange           89       45    30    14    32.6%    91       45    32    14    33.0%
         Southern   San Diego        54       13    35    6     43.5%    54       11    21    22    60.2%
  2016   Central    Madera           160      0     0     160   100.0%   161      0     0     161   100.0%
         Southern   Imperial         40       8     16    16    60.0%    42       1     1     40    96.4%
         Southern   Orange           127      18    64    45    60.6%    127      9     51    67    72.8%
         Southern   Riverside        45       17    17    11    43.3%    45       17    14    14    46.7%
  2017   Central    Fresno           511      0     7     504   99.3%    513      0     0     513   100.0%
         Central    Kern             5        0     1     4     90.0%    5        0     0     5     100.0%
         Central    Madera           403      0     0     403   100.0%   401      0     0     401   100.0%
         Central    Merced           57       0     0     51    100.0%   57       0     0     57    100.0%
         Central    Tulare           71       0     6     65    95.8%    71       0     0     71    100.0%
         Southern   Imperial         33       0     15    18    77.3%    37       1     0     36    97.3%
         Southern   Los Angeles      1,123    207   513   403   58.7%    1,119    27    139   953   91.4%
         Southern   Orange           141      23    65    52    60.6%    141      11    31    99    81.2%
         Southern   Riverside        1,093    199   453   441   61.1%    1,101    113   169   819   82.1%
         Southern   San Bernardino   719      82    270   367   69.8%    722      28    101   593   89.1%
         Southern   San Diego        139      27    54    58    61.2%    139      17    37    85    74.5%

![County-level frequencies of the resistant allele of the 1016 mutation locus by year.](tjz076f0003){#F3}

![County-level frequencies of the resistant allele of the 1534 mutation locus by year.](tjz076f0004){#F4}

Discussion {#s9}
==========

The introduction and establishment of *Ae. aegypti* in California have led to an increased risk of local transmission of arboviruses in the state ([@CIT0011]). Travel-associated cases of chikungunya, dengue, and Zika viruses have resulted in local outbreaks of disease in other states and U.S. territories (Florida, Texas, and Puerto Rico) with established populations of this mosquito species ([@CIT0019], [@CIT0008], [@CIT0020], [@CIT0001], [@CIT0006]). In response to this new threat, CDPH and local vector control agencies have developed invasive *Aedes* mosquito surveillance and response plans that recommend the use of adulticides in the event of local disease transmission.

Understanding the resistance profiles of *Ae. aegypti* populations in the state is imperative for selecting and deploying appropriate pesticides in the event of local disease transmission. If, for instance, a population is highly resistant to most pyrethroid insecticides, effective control will require the use of an alternative class of insecticide such as organophosphates. The results of these two *kdr* assays indicate that such measures may need to be taken, particularly in the Central Valley region of the state. The extremely high and fixed resistant mutations observed in the central population could result in control failure if pyrethroid insecticides were to be used to control adult mosquitoes during a local transmission event. Although the *kdr* resistance profiles for the southern population show a high percentage of susceptible alleles remaining, the proportion of resistant alleles for both the V1016I and F1534C loci have increased steadily since 2015 and will need to be continually monitored. At the county level, Orange County clearly demonstrates that these resistance profiles can change rapidly over time. This knowledge supports the ongoing implementation by local vector control agencies of integrated vector management methods, including pesticide rotation and source reduction, to prevent further resistance from developing.

Additional research is essential to evaluate the efficacy of commonly used adulticides against *Ae. aegypti* in California. Biological assays, such as bottle bioassays and outdoor cage trials that challenge live mosquitoes against diagnostic and label doses of insecticides, are needed to determine whether functional resistance is present in local mosquito populations. Unfortunately, it can be difficult to collect the large numbers of mosquitoes required for these types of assays. Biochemical assays focusing on enzymatic activity in adult female mosquitoes could reveal metabolic mechanisms behind resistance in local *Ae. aegypti* populations. The data obtained from these molecular assays, in conjunction with data from the field, biochemical assays, and bottle bioassays, will provide vector control agencies with comprehensive information on the pesticide resistance profile of local *Ae. aegypti* populations. Such information will help ensure that the pesticides selected for adult mosquito control are effective in preventing or interrupting local transmission of dengue, chikungunya, or Zika viruses in California.
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